Figueiredo IV - Search Results

1

[Correction to the article "Medication Reconciliation During Admission to an Internal Medicine Department: A Pilot Study", Published as Ahead of Print on Acta Med Port 2022.].

Costa E Silva T, Dias P, Alves E Cunha C, Feio J, Lavrador M, Oliveira J, Figueiredo IV, Rocha MJ, Castel-Branco M. Costa E Silva T, et al. Among authors: figueiredo iv. Acta Med Port. 2022 Sep 1;35(9):701-702. doi: 10.20344/amp.18348. Epub 2022 Sep 1. Acta Med Port. 2022. PMID: 36334082 Free article. Portuguese.

2

Influence of administration vehicles and drug formulations on the pharmacokinetic profile of lamotrigine in rats.

Castel-Branco MM, Figueiredo IV, Falcão AC, Macedo TR, Caramona MM. Castel-Branco MM, et al. Among authors: figueiredo iv. Fundam Clin Pharmacol. 2002 Oct;16(5):331-6. doi: 10.1046/j.1472-8206.2002.00096.x. Fundam Clin Pharmacol. 2002. PMID: 12602457

3

Relationship between plasma and brain levels and the anticonvulsant effect of lamotrigine in rats.

Castel-Branco M, Lebre V, Falcão A, Figueiredo I, Caramona M. Castel-Branco M, et al. Eur J Pharmacol. 2003 Dec 15;482(1-3):163-8. doi: 10.1016/j.ejphar.2003.09.065. Eur J Pharmacol. 2003. PMID: 14660018

4

Lamotrigine kidney distribution in male rats following a single intraperitoneal dose.

Castel-Branco MM, Falcão AC, Figueiredo IV, Macedo TR, Caramona MM. Castel-Branco MM, et al. Among authors: figueiredo iv. Fundam Clin Pharmacol. 2004 Feb;18(1):51-5. doi: 10.1046/j.0767-3981.2003.00210.x. Fundam Clin Pharmacol. 2004. PMID: 14748754

5

Neuropharmacokinetic characterization of lamotrigine after its acute administration to rats.

Castel-Branco MM, Falcao AC, Figueiredo IV, Caramona MM, Lanao JM. Castel-Branco MM, et al. Among authors: figueiredo iv. Methods Find Exp Clin Pharmacol. 2005 Oct;27(8):539-45. doi: 10.1358/mf.2005.27.8.928299. Methods Find Exp Clin Pharmacol. 2005. PMID: 16273133 Free article.

6

Lamotrigine pharmacokinetic/pharmacodynamic modelling in rats.

Castel-Branco MM, Falcão AC, Figueiredo IV, Caramona MM. Castel-Branco MM, et al. Among authors: figueiredo iv. Fundam Clin Pharmacol. 2005 Dec;19(6):669-75. doi: 10.1111/j.1472-8206.2005.00380.x. Fundam Clin Pharmacol. 2005. PMID: 16313279

7

Enantioselective HPLC-UV method for determination of eslicarbazepine acetate (BIA 2-093) and its metabolites in human plasma.

Alves G, Figueiredo I, Castel-Branco M, Loureiro A, Fortuna A, Falcão A, Caramona M. Alves G, et al. Biomed Chromatogr. 2007 Nov;21(11):1127-34. doi: 10.1002/bmc.858. Biomed Chromatogr. 2007. PMID: 17594694

8

Simultaneous and enantioselective liquid chromatographic determination of eslicarbazepine acetate, S-licarbazepine, R-licarbazepine and oxcarbazepine in mouse tissue samples using ultraviolet detection.

Alves G, Figueiredo I, Castel-Branco M, Loureiro A, Falcão A, Caramona M. Alves G, et al. Anal Chim Acta. 2007 Jul 16;596(1):132-40. doi: 10.1016/j.aca.2007.05.056. Epub 2007 Jun 3. Anal Chim Acta. 2007. PMID: 17616250

9

Stereoselective disposition of S- and R-licarbazepine in mice.

Alves G, Figueiredo I, Falcão A, Castel-Branco M, Caramona M, Soares-Da-Silva P. Alves G, et al. Chirality. 2008 Jun;20(6):796-804. doi: 10.1002/chir.20546. Chirality. 2008. PMID: 18306292 Free article.

10

Disposition of eslicarbazepine acetate in the mouse after oral administration.

Alves G, Figueiredo I, Castel-Branco M, Lourenço N, Falcão A, Caramona M, Soares-da-Silva P. Alves G, et al. Fundam Clin Pharmacol. 2008 Oct;22(5):529-36. doi: 10.1111/j.1472-8206.2008.00617.x. Epub 2008 Aug 15. Fundam Clin Pharmacol. 2008. PMID: 18710399

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters